# ACID-BASE DISTURBANCES

GENERAL

### 定義

• **Acidemia** → pH <7.36, **alkalemia** → pH >7.44; pH = 6.10 + log(\[HCO3\]/\[0.03xPCO2\])

• **Acidosis** → process that ↑ \[H+\] or ↓ pH by ↓ HCO3 or ↑ PaCO2

• **Alkalosis** → process that ↓ \[H+\] or ↑ pH by ↑ HCO3 or ↓ PaCO2

• Primary disorders: metabolic acidosis or alkalosis, respiratory acidosis or alkalosis

• Compensation

Respiratory: hyper/hypoventilation alters PaCO2 to counteract 1° metabolic process

Renal: excretion/retention of H+/HCO3– to counteract 1° respiratory process

Respiratory compensation occurs in mins-hrs; renal compensation takes days

_Compensation usually never fully corrects pH;_ if pH normal, consider mixed disorder

<table><colgroup><col> <col> <col></colgroup><tbody><tr><td colspan="3"><p><b>Consequences of Severe Acid-Base Disturbances</b> <span>(</span><span><i>NEJM</i></span> <span>1</span><span>998;338:26 &amp;</span> <span>1</span><span>07)</span></p></td></tr><tr><td><p><b>Organ System</b></p></td><td><p><b>Acidemia (pH</b> &lt;<b>7.20)</b></p></td><td><p><b>Alkalemia (pH</b> &gt;<b>7.60)</b></p></td></tr><tr><td><p>Cardiovascular</p></td><td><p>↓ contractility, arteriolar vasodilation</p><p>↓ MAP &amp; CO; ↓ response to catecholamines</p><p>↑ risk of arrhythmias</p></td><td><p>Arteriolar vasoconstriction</p><p>↓ coronary blood flow</p><p>↑ risk of arrhythmias</p></td></tr><tr><td><p>Respiratory</p></td><td><p>Hyperventilation, ↓ resp. muscle strength</p></td><td><p>Hypoventilation</p></td></tr><tr><td><p>Metabolic</p></td><td><p>↑ K (resp. &gt; metab.), insulin resistance</p></td><td><p>↓ K, Ca, Mg, PO<sub>4</sub></p></td></tr><tr><td><p>Neurologic</p></td><td><p>Δ MS</p></td><td><p>Δ MS, seizures, tetany</p></td></tr></tbody></table>

### Workup 
> (_NEJM_ 2014;371:1434)

• **Traditional or physiologic approach** (Brønsted-Lowry 定義 of acids & bases)

Determine **primary disorder:** ✔ pH, PaCO2, HCO3

Determine if **degree of compensation** is appropriate

![](https://i.imgur.com/9c8s9gs.jpg)

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>Compensation for Acid/Base Disorders</b> <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>4;37</span><span>1</span><span>:</span><span>1</span><span>434)</span></p></td></tr><tr><td><p><b>Primary Disorder</b></p></td><td><p><b>Expected Compensation</b></p></td></tr><tr><td><p>Metabolic acidosis</p></td><td><p>↓ P<sub>a</sub>CO<sub>2</sub> = 1.2 × ΔHCO<sub>3</sub></p><p>or P<sub>a</sub>CO<sub>2</sub> = (1.5 × HCO<sub>3</sub>) + 8 ± 2 (Winters’ formula)</p><p>(also, P<sub>a</sub>CO<sub>2</sub> ≈ last 2 digits of pH)</p></td></tr><tr><td><p>Metabolic alkalosis</p></td><td><p>↑ P<sub>a</sub>CO<sub>2</sub> = 0.7 × ΔHCO<sub>3</sub></p><p>or P<sub>a</sub>CO<sub>2</sub> = 0.7 (HCO<sub>3</sub>-24) + 40 ± 2 or HCO<sub>3</sub> + 15</p></td></tr><tr><td><p>Acute respiratory acidosis</p></td><td><p>↑ HCO<sub>3</sub> = 0.1 × ΔP<sub>a</sub>CO<sub>2</sub></p><p>(also, ↓ pH = 0.008 × ΔP<sub>a</sub>CO<sub>2</sub>)</p></td></tr><tr><td><p>Chronic respiratory acidosis</p></td><td><p>↑ HCO<sub>3</sub> = 0.35 × ΔP<sub>a</sub>CO<sub>2</sub></p><p>(also, ↓ pH = 0.003 × ΔP<sub>a</sub>CO<sub>2</sub>)</p></td></tr><tr><td><p>Acute respiratory alkalosis</p></td><td><p>↓ HCO<sub>3</sub> = 0.2 × ΔP<sub>a</sub>CO<sub>2</sub></p><p>(also, ↑ pH = 0.008 × ΔP<sub>a</sub>CO<sub>2</sub>)</p></td></tr><tr><td><p>Chronic respiratory alkalosis</p></td><td><p>↓ HCO<sub>3</sub> = 0.4 × ΔP<sub>a</sub>CO<sub>2</sub></p></td></tr></tbody></table>

• **Alternative approaches**

Base excess/deficit (_NEJM_ 2018;378:1419)

Strong ion difference or “Stewart Method” (_NEJM_ 2014;371:1821)

### 
> Mixed disorders (more than one primary disorder at the same time)

• If compensation less or greater than predicted, may be two disorders:

PaCO2 too low → concomitant 1° resp. alk.; PaCO2 too high → concomitant 1° resp. acid.

HCO3 too low → concomitant 1° met. acid.; HCO3 too high → concomitant 1° met. alk.

• Normal pH, _but..._

↑ PaCO2 + ↑ HCO3 → resp. acid. + met. alk.

↓ PaCO2 + ↓ HCO3 → resp. alk. + met. acid.

Normal PaCO2 & HCO3, _but_ ↑ AG → AG met. acid. + met. alk.

Normal PaCO2, HCO3, & AG → no disturbance _or_ non-AG met. acid. + met. alk.

• _Cannot_ have resp. acid. (hypoventilation) and resp. alk. (hyperventilation) simultaneously

### Figure 4-1 Acid-base nomogram

![](https://i.imgur.com/wv8DQYj.jpg)

(Adapted from Brenner BM, ed., _Brenner & Rector’s The Kidney_, 8th ed., 2007; Ferri F, ed. _Practical Guide to the Care of the Medical Patient_, 7th ed., 2007)

• **ABG vs. VBG:** concordant for pH (~0.04), HCO3 (~2 mEq) but **not** PCO2 (~8±17 mmHg)

VBG can be used to _screen_ for hypercarbia with PCO2 cutoff ≥45 mmHg (100% Se),

but may not accurately assess _degree_ of hypercarbia (_Am J Emerg Med_ 2012;30:896)

# METABOLIC ACIDOSIS

## Initial workup 
> (_NEJM_ 2014;371:1434)

• ✔ **anion gap** (AG) = Na+ – (Cl– + HCO3–) = unmeasured anions – unmeasured cations

if ↑ glc, use measured _not_ corrected Na

expected AG is \[albumin\] × 2.5 (ie, 10 if albumin is 4 g/dL, 7.5 if albumin is 3 g/dL)

↑ AG → ↑ unmeasured anions such as organic acids, phosphates, sulfates

↓ AG → ↓ alb or ↑ unmeasured cations (Ca, Mg, K, Li, Ig), bromide/iodine toxicity

• If ↑ AG, ✔ **delta-delta** (Δ/Δ = ΔAG/ΔHCO3) to assess if there is an additional metabolic

acid-base disturbance; ΔAG = (calculated AG – expected AG), ΔHCO3 = (24 – HCO3)

Δ/Δ = 1–2 → pure AG metabolic acidosis

Δ/Δ < 1 → AG metabolic acidosis _and_ simultaneous non-AG acidosis

Δ/Δ > 2 → AG metabolic acidosis _and_ simultaneous metabolic alkalosis

For pure lactic acidosis Δ/Δ 1.6 b/c of slow lacatate clearance

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>原因 of AG Metabolic Acidosis</b></p></td></tr><tr><td><p><b>Ketoacidosis</b></p></td><td><p><b>Diabetes mellitus</b>, alcoholism, starvation <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>4;372:546)</span></p></td></tr><tr><td><p><b>Lactic acidosis</b> <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>4; 37</span><span>1</span><span>:2309)</span></p></td><td><p><b>Type A:</b> hypoxic (eg, shock, mesenteric ischemia, CO poisoning, cyanide)</p><p><b>Type B:</b> nonhypoxic. ↓ clearance (eg, hepatic dysfxn) or ↑ generation [eg, malig, EtOH, thiamine def., meds (metformin, NRTIs, salicylates, propylene glycol, propofol, isoniazid, linezolid)]</p><p><b><small>D</small>-lactic acidosis:</b> short bowel syndrome → precip by glc ingest → metab by colonic bacteria to <small>D</small>-lactate; not detected by standard lactate assay</p></td></tr><tr><td><p><b>Renal failure</b></p></td><td><p>Accumulation of organic anions (eg, phosphates, sulfates, etc.)</p></td></tr><tr><td><p><b>Ingestions</b></p></td><td><p><b>Glycols:</b> <i>Ethylene</i> (antifreeze) → metab to glycolic and oxalic acids</p><p><i>Propylene</i> (pharmaceutical solvent, eg, IV diazepam, lorazepam, and phenobarbital; antifreeze) → lactic acidosis</p><p><i>Diethylene</i> (brake fluid) → diglycolic acid</p><p><b>5-oxoproline</b> (pyraglutamic acid): acetaminophen → ↑ organic acid 5- oxoproline in susceptible 病人 (malnourished, female, renal failure)</p><p><b>Methanol</b> (windshield fluid, antifreeze, solvents, fuel): metab to formic acid</p><p><b>Aspirin</b>: early resp alkalosis (CNS stim) + late metab acidosis (impairs oxidative phosphorylation → inorganic acids (eg, ketones, lactate)</p></td></tr></tbody></table>

“GOLD MARK” = Glycols, Oxoproline, Lactic, D-Lactic, Methanol, ASA, Renal, Ketoacidosis

## Workup for AG metabolic acidosis

• ✔ for **ketonuria** (dipstick acetoacetate) or plasma β-hydroxybutyrate (βOHB)

nb, urine acetoacetate often not present in early ketoacidosis due to shunting to βOHB; ∴ acetoacetate may later turn ⊕ but does not signify worsening disease

• If ⊖ ketones, ✔ **renal function**, **lactate**, **toxin screen**, and **osmolal gap**

• If obtunded or ↑↑ AG, check **osmolal gap** (OG) = measured osmoles – calculated osmoles

calculated osmoles = (2 × Na) + (glucose/18) + (BUN/2.8) (+ \[EtOH/4.6\] if have EtOH level and want to test if other ingestions)

OG >10 → suggests ingestion (see below) but lacks specificity (can be elevated in lactic acidosis, DKA, and alcoholic ketoacidosis)

high-dose lorazepam (>10 mg/h) a/w propylene glycol intoxication

OG & AG vary based on timing, initially OG ↑, then ↓ with metabolism as AG ↑

![](https://i.imgur.com/4oHI08b.jpg)

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>原因 of Non-AG Metabolic Acidosis</b></p></td></tr><tr><td><p><b>GI losses of HCO<sub>3</sub></b></p></td><td><p>Diarrhea, intestinal or pancreatic fistulas or drainage</p></td></tr><tr><td><p><b>RTAs</b></p></td><td><p><i>See section on renal tubular acidoses below</i></p></td></tr><tr><td><p><b>Early renal failure</b></p></td><td><p>Impaired generation of ammonia</p></td></tr><tr><td><p><b>Ingestions</b></p></td><td><p>Acetazolamide, sevelamer, cholestyramine, toluene</p></td></tr><tr><td><p><b>Dilutional</b></p></td><td><p>Due to rapid infusion of bicarbonate-free IV fluids</p></td></tr><tr><td><p><b>Posthypocapnia</b></p></td><td><p>Respiratory alkalosis → renal wasting of HCO<sub>3</sub>; rapid correction of resp. alk. → transient acidosis until HCO<sub>3</sub> regenerated</p></td></tr><tr><td><p><b>Ureteral diversion</b></p></td><td><p>Colonic Cl<sup>–</sup>/HCO<sub>3</sub><sup>–</sup> exchange, ammonium reabsorption</p></td></tr></tbody></table>

## Workup for non-AG metabolic acidosis

• Evaluate history for causes (see above)

• ✔ **urine anion gap** (UAG) = (UNa + UK) – UCl

UAG = unmeasured anions – unmeasured cations; NH4+ is primary unmeasured cation (represented by UCl). UAG is indirect assay for renal H+ excretion.

• ⊖ UAG → ↑ renal NH4+ excretion → appropriate renal response to acidemia

Ddx: GI causes (diarrhea, fistulas, ureteral diversion), IV NS, proximal RTA, ingestions

• ⊕ UAG → failure of kidneys to generate NH4+

Ddx: distal (type 1, usually ↓ K) or hypoaldo (type IV, usually ↑ K) RTA, early renal failure

• UAG unreliable in polyuria, Na depletion (UNa <20), UpH >6.5 & HAGMA (causes ⊕ UAG b/c excretion of organic anions). Then use UOsm gap = measured UOsm – \[2×(Na+ + K+) + BUN + glc (mmol/L)\]. UOsm gap <40 mmol/L indicates impaired NH4+ excretion.

## Renal tubular acidoses (RTAs) 
> (_Int J Clin Pract_ 2011;65:350)

• **Proximal** (Type II): ↓ proximal reabsorption of HCO3

1° (Fanconi’s syndrome) = ↓ proximal reabsorption of HCO3, PO4, glc, amino acids

Acquired: paraprotein (MM, amyloidosis), metals (Pb, Cd, Hg, Cu), ↓ vit D, PNH, renal Tx

Meds: acetazolamide, aminoglycosides, ifosfamide, cisplatin, topiramate, tenofovir

• **Distal** (Type I): defective distal H+ secretion

1°, autoimmune (Sjögren’s, RA, SLE), hypercalciuria, meds (ampho, Li, ifosfamide); normally a/w ↓ K; if with ↑ K → sickle cell, obstruction, renal transplant

• **Hypoaldo** (Type IV): hypoaldo → ↑ K → ↓ NH3 synthesis → ↓ urine acid-carrying capacity

↓ renin: diabetic nephropathy, NSAIDs, chronic interstitial nephritis, calcineurin inh, HIV

↓ aldo production: 1° AI, ACEI/ARBs, heparin, severe illness, inherited (↓ 21-hydroxylase)

↓ response to aldosterone

meds: K-sparing diuretics, TMP-SMX, pentamidine, calcineurin inhibitors

tubulointerstitial disease: sickle cell, SLE, amyloid, DM

• Combined (Type III): rarely discussed or clinically relevant, also called juvenile RTA, has distal & proximal features, can be due to carbonic anhydrase II deficiency

![](https://i.imgur.com/BEbiVTh.jpg)

aUrine pH will rise above 5.3 in the setting of HCO3 load

bFeHCO3 should be checked after an HCO3 load

cSee above for causes of distal RTA (Type I) associated with hyperkalemia

## Figure 4-2 Approach to metabolic acidosis

![](https://i.imgur.com/u9WmvuY.jpg)

## 治療 of severe metabolic acidoses (pH <**7.2)
> (_Nat Rev Nephrol_ 2012;8:589)

• DKA: insulin, IVF, K repletion (_NEJM_ 2015;372:546); AKA: dextrose, IVF, replete K, Mg, PO4

• Lactic acidosis: treat underlying condition, avoid vasoconstrictors, avoid “Type B” meds

• Renal failure: hemodialysis

• Methanol & ethylene glycol: fomepizole (20 mg/dL), vit. B1 & B6 (ethylene glycol), folate (methanol), dialysis (if AKI, VS unstable, vision Δ or >50 mg/dL) (_NEJM_ 2018;378:270)

• Alkali therapy: if pH <7.1 or <7.2 and co-existing AKI (_Lancet_ 2018;392:21)

• NaHCO3: amps by IV push or infusion of three 50-mmol amps in 1 L D5W if less urgent

can estimate mmol of HCO3 needed as \[desired-current HCO3\]serum × wt (kg) × 0.4

side effects: ↑ volume, ↑ Na, ↓ ICa, ↑ PaCO2 (& ∴ intracellular acidosis; ∴ _must ensure adequate ventilation_ to blow off CO2)

# METABOLIC ALKALOSIS

## 病生理 
> (_Clin Physio Acid-Base_ 2001; _CJASN_ 2008;3:1861)

• Saline-responsive 原因 require _initiating event_ and _maintenance phase_

### • _Initiating event:_ net HCO3− reabsorption (due to loss of volume, Cl\-, and/or K+) or loss of H+

Loss of H+ (± Cl\-) from GI tract, kidneys, or transcellular shift in hypokalemia

**Contraction alkalosis:** loss of HCO3\-\-poor fluid → extracellular fluid “contracts” around fixed amount of HCO3\- → ↑ HCO3\- concentration

**Exogenous alkali:** iatrogenic HCO3\- (with renal impairment), milk-alkali syndrome

**Posthypercapnia:** resp. acidosis → compensation with H+ excretion and HCO3\- retention; rapid correction of hypercapnia (eg, intubation) → transient excess HCO3\-

### • _Maintenance phase_

* Volume depletion → ↑ ATII → ↑ PCT reabsorption of HCO3\- & ↑ aldosterone (see below)
*  Cl\- **depletion** → ↓ Cl\- uptake in macula densa → ↑ RAS & ↑ CCD Cl\-/HCO3\- exchanger
* * Hypokalemia → transcellular K+/H+ exchange; intracellular acidosis → HCO3\- reabsorption and ammoniagenesis & ↑ distal H+\-K+\-ATPase activity → HCO3\- retention
* * Hyperaldosteronism (1° or 2°) → ↑ CCD α-intercalated H+ secretion with HCO3\- retention & Na+ reabsorption in principal cell → H+ secretion (for electrical neutrality)

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><a id="page_4-5"></a><p><b>原因 of Metabolic Alkalosis</b></p></td></tr><tr><td><p><b>Saline responsive</b></p><p>UCl &lt; 25</p></td><td><p><b>GI loss of H</b><sup>+</sup>: emesis, NGT suction, villous adenoma, chloridorrhea</p><p><b>Renal loss</b>: loop/thiazide, ↓ Cl intake, milk-alkali, Pendred syndrome</p><p>Posthypercapnia, sweat losses in cystic fibrosis</p></td></tr><tr><td><p><b>Saline resistant</b></p><p>UCl &gt;40</p></td><td><p><i>Hypertensive</i> <b>(mineralocorticoid excess)</b></p><p>1° hyperaldosteronism (eg, Conn’s)</p><p>2° hyperaldosteronism (eg, renovascular dis., renin-secreting tumor)</p><p>Non-aldo (Cushing’s, Liddle’s, exogenous mineralocorticoids, licorice)</p><p><i>Normotensive</i></p><p>Severe hypokalemia (K&lt;2); exogenous alkali load (w/ AKI or ↓ vol)</p><p>Bartter’s syndrome (loop-like); Gitelman’s syndrome (thiazide-like)</p></td></tr></tbody></table>

## Workup

• Check **volume status** and **U****Cl**

UCl <25 mEq/L → saline responsive

UCl >40 mEq/L → saline resistant (unless currently receiving diuretics)

(UNa unreliable determinant of volume status in alkalemia → ↑ HCO3\- excretion → ↑ Na excretion; negatively charged HCO3\- with Na+ maintaining electrical neutrality)

If UCl >40 and volume replete, ✔ UK; UK < 20 laxative abuse; UK >30, ✔ **blood pressure**

### Figure 4-3 Approach to metabolic alkalosis

![](https://i.imgur.com/ydNc2Mo.jpg)

## 治療 of severe metabolic alkalosis (pH >**7.6)** (_JASN_ 2012;23:204)

• If saline responsive: resuscitate with Cl-rich solution (NS), replete K, d/c diuretics cardiopulmonary disease precludes hydration, can use KCl, acetazolamide, HCl

• If NGT drainage that cannot be stopped: PPI or H2\-blocker (_Clin Nephro_ 2006;66:391)

• Hyperaldosteronism: treat underlying condition, K-sparing diuretic, resect adenoma if 1o

# RESPIRATORY ACIDOSIS 
> (_NEJM_ 1989;321:1223; _Crit Care_ 2010;14:220)

## 原因 
> (also see “Hypercapnia”; PaCO2 = VCO2/VE(1-VD/VT); VE= RR x VT) [[02-15-Respiratory-Failure]]

• ↑ **CO2 production** (↑ VCO2): fever, thyrotoxicosis, sepsis, steroids, overfeeding (carbs)

• **CNS depression** (↓ RR and/or VT): sedatives (opiates, benzos, etc.), CNS trauma, central sleep apnea, obesity hypoventilation, hypothyroidism

• **Neuromuscular disorders** (↓ VT)**:** Guillain-Barré, poliomyelitis, ALS, MS, paralytics, myasthenia gravis, muscular dystrophy, severe ↓ P & K, high spinal cord injury

• **Chest wall** (↓ VT): PTX, hemothorax, flail chest, kyphoscoliosis, ankylosing spondylitis

• **Upper airway** (↓ VT)**:** foreign body, laryngospasm, OSA, esophageal intubation

• **Lower airway (gas exchange)** (↑ VD and/or ↓ VT): asthma, COPD, pulm edema, IPF

Often hypoxia → ↑ RR → resp. alk., but muscle fatigue → resp. acid

• Post infusion of bicarbonate in acidemic Pt with limited ability to ↑ minute ventilation

# RESPIRATORY ALKALOSIS

## 原因 (_NEJM_ 2002;347:43; _Crit Care_ 2010;14:220)

• **Hypoxia** → **hyperventilation:** pneumonia, CHF, PE, restrictive lung disease, anemia

• **Primary hyperventilation**

CNS stimulation, pain, anxiety, trauma, stroke, CNS infection, pontine tumors

drugs: salicylates toxicity (early), β-agonists, progesterone, methylxanthines, nicotine

pregnancy, sepsis, hepatic failure, hyperthyroidism, fever

• **Pseudorespiratory alkalosis:** ↓ perfusion with preserved ventilation (eg, CPR, severe HoTN) → ↓ delivery of CO2 to lungs for excretion; low PaCO2 but ↑ tissue CO2
